Age-related Macular Degeneration Market Trends

Growth Drivers

• Growing Burden of AMD - The worldwide burden of AMD proceeds to rise at an exceptional speed as the worldwide populace develops and the socioeconomics reflects a larger part of more seasoned individuals. As of the World Health Organization, there are as of now around 1.1 billion tobacco clients within the world, with that figure likely to twofold by 2050 on the off chance that current patterns proceed. As a result, cigarette utilization is thought to be a major donor to the worldwide increment in AMD predominance. 
• Government Initiatives - Public health initiatives pointed toward bringing issues to light about AMD and advancing early identification, for example, those drove by groups like Fighting Blindness Canada in Canada, energize opportune treatment commencement and extensive sickness the board. These initiatives are intended to reach more people in need of treatment, which is likely to increase demand on the market.

Challenges

• Lack of Effective Treatments for Dry AMD - There is currently no cure for AMD and there are only a few approved treatments available for the wet form of the disease. Dry AMD is the more common form, accounting for about 85% of cases but there are no approved drugs specifically for dry AMD. While some treatments for wet AMD can be used off-label for dry AMD they are not as effective and can be expensive.
• High Cost of Treatments is Expected to Hinder the Market Growth in the Forecast Period
• Complexities Associated with the Development of New treatments are estimated to hinder market growth in the upcoming period